Publication: 810

CALGB 50401: A randomized trial of lenalidomide alone versus lenalidomide plus rituximab in patients with recurrent follicular lymphoma.
   Google Scholar   
Citation:
J Clin Oncol vol 30 (15 suppl) abstr 80000
Meeting Instance:
ASCO 2012
Year:
2012
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
2102  
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
             
Networks:
 
Study
CALGB-50401
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: